As part of our Think FASTT series, join us for a fireside chat with Dr. Jennifer Doudna on Wednesday, November 17th at 4:15 pm EST (1:15 pm PST). A renowned biochemist, Dr. Doudna received the 2020 Nobel Prize in Chemistry, along with Dr. Emmanuelle Charpentier, for their co-creation of CRISPR technology that is revolutionizing the biological sciences.
Hosting this virtual event will be BenchSci's Senior Vice President of Product and Science, Casandra Mangroo.
Be a part of this candid conversation where Dr. Doudna shares some of her unique experiences and perspectives, with an opportunity to engage with Dr. Doudna during the Q&A session.
Please use your business email to register using the button below.
 |
Dr. Jennifer DoudnaBiochemist at UC Berkeley and co-inventor of CRISPR-Cas9 technology |
Dr. Jennifer Doudna is a Professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley. Her discovery of CRISPR-Cas9 as a genome engineering technology, along with Dr. Emmanuelle Charpentier, earned her multiple awards including the 2020 Nobel Prize in Chemistry. In addition to her scientific achievements, Doudna is a leader and advocate for ethical approaches to the development of policies focused on the safe use of CRISPR technology, and advises for several companies that are innovating new applications for CRISPR technology.
 |
Casandra MangrooSVP of Product and Science at BenchSci |
Casandra Mangroo is the Senior Vice President of Product and Science at BenchSci. In her role, Mangroo has been instrumental in applying machine learning to accelerate drug discovery at 15 top 20 pharmaceutical companies, empowering tens of thousands of scientists daily. She is passionate about solving scientific research challenges within organizations and driving impact by developing and applying cutting-edge deep learning technology, used globally in the world's leading research laboratories.